Tag: Crohn’s treatment side effects
Cancer Therapy Breakthroughs Could Transform Crohn’s Treatment
Groundbreaking research is adapting successful cancer therapies to create more targeted treatments for Crohn’s and ulcerative colitis. These NK cell therapies could potentially calm overactive immune responses without the harsh side effects of current medications.
New Treatment Hope for Perianal Fistulizing Crohn’s Disease
New evidence-based treatment guidelines for perianal fistulizing Crohn’s disease offer hope through structured, multidisciplinary care approaches. The comprehensive algorithm emphasizes early intervention, coordinated treatment, and emerging therapies for better patient outcomes.
New Hope: Switching Infliximab Delivery Could Change IBD Life
New research shows IBD patients can successfully switch from IV to subcutaneous infliximab while maintaining remission, with over 95% staying in remission for at least one year. This could transform treatment by offering more convenience and flexibility without sacrificing effectiveness.
New Crohn’s Treatment Shows 70% Success Rate in Early Trial
Amorphical’s early clinical trial shows 70% of Crohn’s patients experienced significant improvement using a novel calcium-based treatment. This research represents a fundamentally different approach from traditional IBD therapies, potentially offering hope with fewer side effects.
The Personal Treatment Revolution in Crohn’s Disease Care
The treatment landscape for Crohn’s disease has transformed dramatically, moving from limited one-size-fits-all options to personalized therapies tailored to individual symptoms, medical history, and lifestyle preferences. This shift represents more than medical progress—it offers genuine hope for better quality of life and long-term relief for the IBD community.
Steroids and Crohn’s: The Relief vs. Risk Reality Check
Steroids can provide rapid relief for Crohn’s flares, but they come with important limitations and risks. We explore the reality of making this treatment decision and what it means for your long-term IBD management strategy.
New Hope: Could Nerve Stimulation Transform IBD Treatment?
Boomerang Medical has raised $20 million to develop a breakthrough device-based treatment for IBD using gentle electrical nerve stimulation. This approach could offer hope for patients seeking alternatives to traditional drug therapies and surgery.
New Immune Discovery Could Transform Crohn’s Treatment Forever
Researchers have identified specific molecules that turn gut immune cells into troublemakers in Crohn’s disease. This breakthrough could lead to precision treatments that target only problematic immune pathways while preserving overall immune function.
New Single-Cell Research Offers Fresh Hope for Better Crohn’s Treatments
New single-cell research is revealing which specific immune cells drive Crohn’s inflammation, potentially leading to more precise treatments with fewer side effects. This breakthrough could transform how we approach IBD therapy by targeting only problematic cells while preserving helpful immune function.
AstraZeneca’s AZD7798: A Promising New Chapter in Crohn’s Care
AstraZeneca’s AZD7798 represents a precision-targeted approach to Crohn’s treatment that could reduce side effects while improving effectiveness. This Phase II trial offers hope for a fundamentally different way of managing IBD inflammation.
